Yesterday, Loxo Oncology Inc. (NASDAQ:LOXO) saw several of its insiders complete significant stock acquisitions. Dov Goldstein, Chief Financial Officer and Treasurer at the firm, purchased 413,077 shares of Common Stock for $13.00 per share. The stock was also bought indirectly, via Aisling Capital III, LP, of which the insider is a member. Following Goldstein’s first stock acquisition of the fiscal year, he now owns over 3.45 million company shares.
Another insider to buy Loxo shares yesterday was James Barrett. The company Director purchased 230,769 shares of Common Stock at the same price as his fellow insider, and the transaction was also executed indirectly, through NEA Partners 14. Furthermore, one of the firm’s 10% owners, Orbimed Advisors LLC bought 275,385 shares of Common Stock, for $13.00 per share, executing the transaction indirectly through OrbiMed Private Investments V, LP.
Another large shareholder and 10% owner of Loxo Oncology that acquired stock yesterday is Peter Barris. The insider purchased 230,769 shares for $13.00 each share, indirectly, through the same fund as his fellow insider Barrett.